awmsg logo



clopidogrel (Plavix®)


Reference No. 435

Publication date:
19/04/2011


Appraisal information

clopidogrel (Plavix®) film-coated tablet


Company: Sanofi-Aventis Ltd/Bristol-Myers Squibb Pharmaceuticals Ltd
BNF category: Cardiovascular system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 01/09/2011

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, clopidogrel (Plavix®) cannot be endorsed for use within NHS Wales in combination with aspirin for the prevention of atherothrombotic and thromboembolic events in adult patients with atrial fibrillation.
Statement of Advice (SOA)
Download